The estimated Net Worth of Chitra Nayak is at least $141 mil dollars as of 17 August 2023. Ms. Nayak owns over 1,600 units of Invitae Corp stock worth over $117 and over the last 6 years she sold NVTA stock worth over $0. In addition, she makes $141,060 as Independent Director at Invitae Corp.
Chitra has made over 1 trades of the Invitae Corp stock since 2023, according to the Form 4 filled with the SEC. Most recently she bought 1,600 units of NVTA stock worth $102,016 on 17 August 2023.
The largest trade she's ever made was buying 1,600 units of Invitae Corp stock on 17 August 2023 worth over $102,016. On average, Chitra trades about 145 units every 0 days since 2018. As of 17 August 2023 she still owns at least 5,856 units of Invitae Corp stock.
You can see the complete history of Ms. Nayak stock trades at the bottom of the page.
Chitra Nayak serves as Independent Director of the Company. Ms. Nayak currently serves as an advisor to technology startups, and has served as an adjunct faculty member at California State University’s M.B.A. program since January 2019. Ms. Nayak served as the Chief Operating Officer of Comfy, Inc., a real-estate technology company in the machine learning and IoT space, from February 2017 to June 2018, when it was acquired by Siemens, and prior to that, the Chief Operating Officer of Funding Circle Ltd., an online peer-to-peer lending marketplace, from February 2015 to May 2016. Prior to joining Funding Circle, Ms. Nayak worked at Salesforce.com, a cloud computing company, for eight years, serving in a variety of roles including Chief Operating Officer of Platform from February 2013 to January 2015, Senior Vice President of Global Sales Development from February 2008 to January 2013 and Vice President of Marketing Strategy & Operations from February 2007 to January 2008. From 2004 to 2006, Ms. Nayak served as Vice President, Membership Products for California State Automobile Association, a provider of automobile insurance. From 1999 to 2003, Ms. Nayak served as Vice President, Strategy & Operations of Charles Schwab Corporation, an investment and brokerage firm. Prior to that, Ms. Nayak spent six years with the Boston Consulting Group, and four more years with a number of engineering consulting firms. Ms. Nayak holds a B.S. in Engineering from the Indian Institute of Technology, an M.S. in Engineering from Cornell University, and an M.B.A. from Harvard Business School (with honors).
As the Independent Director of Invitae Corp, the total compensation of Chitra Nayak at Invitae Corp is $141,060. There are 10 executives at Invitae Corp getting paid more, with Sean George having the highest compensation of $5,319,510.
Chitra Nayak is 56, she's been the Independent Director of Invitae Corp since 2018. There are 9 older and 10 younger executives at Invitae Corp. The oldest executive at Invitae Corp is Dr. Robert L. Nussbaum, 71, who is the Chief Medical Officer.
Chitra's mailing address filed with the SEC is 1915 SNAPPS FERRY ROAD, BUILDING N, GREENEVILLE, TN, 37745.
Over the last 10 years, insiders at Invitae Corp have traded over $68,349,838 worth of Invitae Corp stock and bought 2,982,686 units worth $18,086,236 . The most active insiders traders include Bros. Advisors Lp Baker Bro..., Bros. Advisors Lpbaker Feli... y James E Deerfield Mgmt L.P..... On average, Invitae Corp executives and independent directors trade stock every 14 days with the average trade being worth of $540. The most recent stock trade was executed by Robert L Nussbaum on 13 June 2023, trading 7,086 units of NVTA stock currently worth $9,779.
invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. specializing in genetic diagnostics for hereditary disorders, invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. choose from our curated panels or design your own test for the same low price. today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. together we can improve healthcare for billions of people.
Invitae Corp executives and other stock owners filed with the SEC include: